The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes.
Maria Giovanna ScaraleMassimiliano CopettiMonia GarofoloAndrea FontanaLucia SalveminiSalvatore De CosmoOlga LamacchiaGiuseppe PennoVincenzo TrischittaClaudia MenzaghiPublished in: Diabetes care (2020)
In type 2 diabetes, hs-CRP and SAP show opposite and synergic associations with all-cause mortality. The use of both markers, possibly in combination with others yet to be unraveled, might improve the ability to predict the risk of death in the real-life setting.